{"@id":"https://bioecon.ru/technology/gene-therapy-for-phagocyte-disorders/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/gene-therapy-for-phagocyte-disorders/","json":"https://cn.bioecon.ru/api/v1/technology/gene-therapy-for-phagocyte-disorders/index.json"},"id":"gene-therapy-for-phagocyte-disorders","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/shandong-shunfeng-biotechnology/","https://bioecon.ru/companies/hangzhou-ruifeng/","https://bioecon.ru/companies/origin-agritech/","https://bioecon.ru/companies/inari-agriculture/"]},"maturity":7,"name":"吞噬细胞遗传缺陷型原发性免疫缺陷基因疗法","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"干细胞动员与外周血CD34+高效富集"},{"n":2,"title":"骨髓髓系特异性启动子慢病毒修饰"},{"n":3,"title":"中性粒细胞呼吸暴发氧化杀菌功能重建"},{"n":4,"title":"清髓预处理后自体干细胞回输重建"}],"summary":"通过自体造血干/祖细胞（HSPC）体外基因修饰与碱基编辑，恢复成熟中性粒细胞与巨噬细胞中缺失的NADPH氧化酶复合物活性，彻底根治慢性肉芽肿病（CGD）及先天性严重吞噬功能障碍。","url":"/technology/gene-therapy-for-phagocyte-disorders/","verified":"2026-11-22"}